Liquidia Financial Statements
NASDAQ: LQDAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Liquidia revenue and earnings
In fiscal 2025, Liquidia generated $158.3 million in revenue, up 1031.2% from fiscal 2024. Liquidia reported a net loss of $68.9 million, compared with a loss of $128.3 million a year earlier. Operating margin was -32.5%.
Diluted earnings per share came in at -$0.80. Over the last 5 fiscal years, LQDA's revenue has grown at a 192.5% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Liquidia income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Revenue | 158.32M | 14.00M | 17.49M | 15.94M | 12.85M | 739.63K | 8.07M |
| Revenue growth (YoY) | +1031.18% | -19.97% | +9.75% | +23.98% | +1637.77% | -90.84% | — |
| Cost of Revenue | — | 5.88M | 2.89M | 2.86M | 3.02M | 237.71K | — |
| Gross Profit | — | 8.12M | 14.60M | 13.08M | 9.83M | 501.92K | — |
| Operating Expenses | — | 129.41M | 87.98M | 51.85M | 43.63M | 59.59M | — |
| Research & Development | 39.28M | 47.84M | 43.24M | 19.43M | 20.52M | 32.22M | 40.49M |
| Selling, General & Admin | 157.18M | 81.57M | 44.74M | — | — | — | — |
| Operating Income | -51.38M | -121.29M | -73.38M | -38.77M | -33.80M | -59.09M | -46.82M |
| Interest Expense | 24.17M | 14.65M | 6.27M | 2.34M | 762.00K | 858.00K | 1.37M |
| Other Income (Expense) | -17.55M | -7.00M | -5.12M | -2.25M | -782.00K | -673.64K | -759.91K |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -68.92M | -128.29M | -78.50M | -41.02M | -34.58M | -59.76M | -47.58M |
| Net Income growth (YoY) | — | — | — | — | — | — | — |
| EPS (Basic) | -0.80 | -1.63 | -1.21 | -0.67 | -0.70 | -1.76 | -2.57 |
| EPS (Diluted) | -0.80 | -1.63 | -1.21 | -0.67 | -0.70 | -1.76 | -2.57 |
| Shares Outstanding (Basic) | 86.06M | 78.71M | 64.99M | 60.96M | 49.68M | 33.89M | 18.48M |
| Shares Outstanding (Diluted) | 86.06M | 78.71M | 64.99M | 60.96M | 49.68M | 33.89M | 18.48M |
| EBITDA | -49.85M | -119.10M | -71.21M | -35.12M | -28.18M | -55.96M | -44.26M |
| Gross Margin | — | 58.00% | 83.49% | 82.06% | 76.48% | 67.86% | — |
| Operating Margin | -32.45% | -866.63% | -419.62% | -243.30% | -262.95% | -7989.03% | -580.07% |
| Net Margin | -43.53% | -916.63% | -448.89% | -257.39% | -269.03% | -8080.11% | -589.48% |
This table shows 7 annual periods of Liquidia's income statement, from FY 2025 back to FY 2019, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow LQDA's reporting calendar. What is a income statement?